Exciting times at Intelligenic Health! We are delighted to announce the UK and European launch of our digital engagement technology, Intelli.
Commenting on the launch Rob Gray, Co-Founder Intelligenic said, “Covid-19 has seen an explosion in the provision of digital engagement strategies and content from pharmaceutical companies to healthcare professionals, but understanding if that content is landing, is really challenging. Intelli, provides an exceptionally rich content engagement environment for healthcare professionals and powers our customers understanding of the interaction with their scientific and proprietary digital content, across both medical and commercial functions.”
Nigel Mansford, Co-Founder Intelligenic added,“We were extremely encouraged by our extensive market testing this summer and are very grateful to the pharma companies that helped us fine tune our product and service proposition. They pointed us to a number of use cases which we’ve now incorporated into our portfolio of engagement solutions.”
Intelli is straightforward, compliant and quick to deploy, supports any distribution channel typically used for digital content deployment and can be used for both copyright and proprietary material, pre licence, post licence, by field teams, and office based Medical, Marketing and Commercial engagement functions. Intelli supports all engagement interfaces, e-mail, one to one interactions, conferences, symposia, KTL engagement and websites.
To find out more about how we can support your product development or brand engagement strategy please contact firstname.lastname@example.org.